EC Gastroenterology and Digestive System

We present an interesting case of liver complication after acute SARS-COV-2 infection associated with neurological complication in a 27-year-old male Cuban patient, who lives in Uruguay. Attended to consultation due to He reports that since the beginning of the year he began to experience pain in Lower limbs with foot cramps that made it impossible to walk at times and felt abdominal pain. After making an exhaustive clinical evaluation of the patient, it was determined that he had a metabolic associated fatty liver disease with sensitive polyneuropathy of the lower limbs. When referring to management, we first observed that vitamin therapy as well as acupuncture help improve the quality of live as well as relieve pain, stress and anxiety. On the other hand, vitamin therapy and physical exercise are two points in common in treatment of both entities.

Although it was shown that acting on the risk factors and modifying them we can achieve a notable improvement and thus ensure a better quality of life for the patient.

Keywords: SARS-COV 2; MAFLD; Liver Enzyme Alterations; Liver Injury

1. Desai AD., et al. “Long term complications of COVID-19”. American Journal of Phisiology Cell Phisiology (2022).
2. Benedetti C., et al. “COVID-19and the Kidneys: An Update”. Frontier in Medicine Nephrology (2020).
3. Aiyegbusi OL., et al. “Symptoms, complications and management of long COVID: a review”. Journal of The Royal Society of Medicine (2021).
4. Chopra V., et al. “Sixty-Day outcomes among patients hospitalized with COVID-19”. Annals of Internal Medicine (2021).
5. Huang C., et al. “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study”. The Lancet 10270 (2021).
6. Zhang C., et al. “Liver Injury in COVID-19: management and challenges”. The Lancet Gastroenterology and Hepatology 5 (2020).
7. Kanmarinaja D., et al. “Review of COVID-19, part 1: Abdominal manifestation in adults and multisystem inflammatory syndrome in children”. Body Imaging (2021).
8. Nardo AD., et al. “Pathophysiological mechanism of liver injury in COVID-19”. Liver International (2021).
9. Wang Y., et al. “SARS-COV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID19”. Journal of Hepatology (2020).
10. Wang Y., et al. “Reply to: Correspondence relating to ¨SARS-COV-2 infection of the liver directly contributes to Hepatic impairment in patients with COVID-19”. Journal of Hepatology (2020).
11. Cai Q., et al. “COVID-19: Abdominal liver function test”. Journal of Hepatology 3 (2020): 566-574.